Sunshine Biopharma Inc Warrant
SBFMW
4 hedge funds and large institutions have $13.3K invested in Sunshine Biopharma Inc Warrant in 2023 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 4 → 4 (0)
0.02% less ownership
Funds ownership: 0.27% → 0.25% (-0.02%)
14% less capital invested
Capital invested by funds: $15.4K → $13.3K (-$2.1K)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$22 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$930 |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$124 |
| 3 |
CS
Clear Street
New York
|
-$22 |
SBFMW Hedge Fund Activity: Q4 2023 in Review
4 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Sunshine Biopharma Inc Warrant (SBFMW) for Q4 2023, worth a combined $13.3K — down 14% from $15.4K a quarter earlier.
Fund positioning in SBFMW was balanced in Q4 2023: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 3 trimmed.
The largest buyer was Bank of America, adding an estimated $22. The largest seller was Citadel Advisors, cutting an estimated $930.
- 4 institutional investors held Sunshine Biopharma Inc Warrant (SBFMW) as of Q4 2023, unchanged from Q3 2023.
- Funds reported $13.3K of Sunshine Biopharma Inc Warrant stock for Q4 2023, down 14% quarter-over-quarter.
- 0 funds opened new Sunshine Biopharma Inc Warrant positions in Q4 2023 and 0 closed out.
- The largest Sunshine Biopharma Inc Warrant buyer in Q4 2023 was Bank of America, an estimated $22 added.
- The largest Sunshine Biopharma Inc Warrant seller in Q4 2023 was Citadel Advisors, an estimated $930 sold.
Based on aggregated 13F filings for Q4 2023.